RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up

  • Dr. Reddy's stock is up on encouraging fiscal fourth-quarter 2025 results, wherein both earnings and revenues beat estimates, driven by higher global generic sales.